Tucker Harrison, DO
Interventional Cardiology · Tulsa, OKNPI 1396004636
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,501 of the $19,498 with a category attached, or 64.1%. 31 manufacturers reported payments, led by Inari Medical, Inc. at 25.2% of the total. Reporting peaked in 2024 at $5,804 and has fallen 51.7% since, to $2,803 in 2025.
Across 240 payments — averaging $81.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$5K
- Penumbra, Inc.$4K
- Boston Scientific$2K
- Abiomed$2K
- Stryker$1K
- Shockwave Medical, Inc$1K
- plus $4K from 25 others
Across 41 payments — averaging $1878.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inari Medical, Inc.$66K
- Stryker$11K
What the payments were for
- Travel & lodging$6,99836%
- Food & beverage$12,50164%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 50 | $4,918 |
| Penumbra, Inc. | 25 | $4,168 |
| Boston Scientific | 34 | $2,364 |
| Abiomed | 24 | $2,106 |
| Stryker | 12 | $1,164 |
| Shockwave Medical, Inc | 10 | $1,064 |
| Abbott | 18 | $757 |
| Cardiovascular Systems Inc. | 5 | $654 |
| Imperative Care, Inc | 3 | $361 |
| Angiodynamics, Inc. | 7 | $317 |
| Bard Peripheral Vascular, Inc. | 2 | $306 |
| Surmodics, Inc. | 3 | $300 |
| Novartis | 11 | $225 |
| Impulse Dynamics (USA) Inc. | 1 | $148 |
| Amgen | 8 | $141 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $67 |
| Boehringer Ingelheim | 4 | $53 |
| Silk Road Medical, Inc. | 1 | $52 |
| Novo Nordisk | 2 | $39 |
| Atricure, Inc. | 1 | $38 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $35 |
| Philips North America LLC | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Mozarc Medical US LLC | 1 | $25 |
| Kestra Medical Technology Services, Inc. | 1 | $23 |
| AstraZeneca | 1 | $21 |
| Baxter Healthcare | 1 | $20 |
| Pfizer | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
| Bridgebio Pharma, Inc. | 1 | $16 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$5,244
- CT THROMBECTOMY SYSTEM KIT$3,455
- Indigo System$3,217
- Impella$1,552
- JETSTREAM$789
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$637
- ANGIOJET$632
- Coronary Orbital Atherectomy System$500
- SYMPHONY CATHETER$361
- FlowTriever$316
- Venclose Maven Catheter$306
- OPTIMIZER$295
- Vascular Lithotripsy$271
- Sublime 014 Rx PTA Balloon Dilatation Catheter$270
- Pounce Thrombectomy$270
- Pounce Venous Thrombectomy System$270
- Penumbra System$266
- ClotTriever$154
- HeartMate$145
- Sublime Radial Access 018 RX PTA Dilatation Catheter$143
How this compares
$19,498 in reported general payments places this provider in the 80th percentile of 110 interventional cardiology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 259 | $260,959 |
| XareltoRivaroxaban | 142 | $142,406 |
| JardianceEmpagliflozin | 36 | $35,792 |
| Repatha SureclickEvolocumab | 30 | $30,282 |
| EntrestoSacubitril/Valsartan | 40 | $29,690 |
| Praluent PenAlirocumab | 11 | $8,979 |
| Repatha SyringeEvolocumab | 17 | $8,918 |
| Atorvastatin Calcium | 361 | $8,408 |
| Metoprolol Succinate | 369 | $5,524 |
| ClopidogrelClopidogrel Bisulfate | 277 | $4,511 |
| Rosuvastatin Calcium | 113 | $2,862 |
| Losartan Potassium | 230 | $2,599 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 17 | $2,465 |
| Ezetimibe | 59 | $2,191 |
| Amlodipine Besylate | 216 | $1,843 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $19 | $260,959259 claims |
| Johnson & JohnsonXarelto | $17 | $142,406142 claims |
| Boehringer IngelheimJardiance | $53 | $35,79236 claims |
| NovartisEntresto | $225 | $29,69040 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 110 interventional cardiology providers in Oklahoma.
Other interventional cardiology in Tulsa
- Kamran MuhammadTulsa$1.4M
- Stanley ZimmermanTulsa$93K
- Matthew ComstockTulsa$69K
- Wayne LeimbachTulsa$68K
- Tom HuTulsa$57K
- Eugene IchinoseTulsa$49K
- Poorya FazelTulsa$29K
- Andrew KurklinskyTulsa$15K
- Stewart KatzTulsa$13K
- Arash KarnamaTulsa$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.